RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Small Cap

-$1.50

EPS Forecast

$169.7

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.50

Revenue Forecast:

$169.7

EPS Surprise Forecast:

$0.002

Revenue Surprise Forecast:

$1

Post-release price volatility - Very high

Post-release Overnight Move:

±10.4%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

53%

Probability of beating revenue consensus:

56%

Probability of beating both EPS & revs consensus:

36%

Probability of missing both EPS & revs consensus:

27%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

1.30

Earnings volatility

EPS standard deviation:

$0.55

Revenue standard deviation:

$19

As % of share price:

2.70% EXTREME UNCERTAINTY

As % of market cap:

0.96% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.79

Revenue 95th %ile:

$194

EPS 75th %ile:

-$1.31

Revenue 75th %ile:

$176

EPS 25th %ile:

-$1.66

Revenue 25th %ile:

$164

EPS 5th %ile:

-$2.12

Revenue 5th %ile:

$149

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$16

Bid-ask per Share:

$0.035